| Patents for A61P - Specific therapeutic activity of chemical compounds or medicinal preparations (3,181) |
|---|
| 09/15/1999 | EP0941100A2 Pharmaceutical compositions containing lamivudine and zidovudine |
| 08/17/1999 | CA2098738C Controlled release oxycodone compositions |
| 08/12/1999 | WO1996037199A8 Use of r-enantiomer of n-propargyl-1-aminoindan, salts, and compositions thereof |
| 08/11/1999 | CN1225587A Compositions comprising an HIV protease inhibitor such as VX 478 and a water soluble vitamin E compound such as vitamin E-TPGS |
| 08/04/1999 | CN1224619A Novel powder compositions |
| 06/30/1999 | CN1221343A Phosphatidic acid-comprising compositions |
| 06/29/1999 | US5916555 Pharmaceutical composition for treatment of diabetes |
| 06/10/1999 | WO1999004765A3 Pharmaceutical compositions containing an effervescent acid-base couple |
| 05/14/1999 | WO1999022749A1 Galenic preparation for prevention and treatment of hepatocarcinoma |
| 05/12/1999 | CN1216256A Galenic preparation for prevention and treatment of hepatocarcinoma |
| 04/15/1999 | WO1999004770A3 A pharmaceutical composition active in reducing production of mcp-1 protein |
| 04/07/1999 | EP0906107A1 Compositions comprising an hiv protease inhibitor such as vx 478 and a water soluble vitamin e compound such as vitamin e-tpgs |
| 03/31/1999 | EP0904087A1 Phosphatidic acid-comprising compositions |
| 03/17/1999 | CN1211190A Natural tea for taking off the effects of drink and process for production thereof |
| 02/18/1999 | WO1999007396A1 Composition comprising propolis and at least an essential oil |
| 02/18/1999 | CA2301068A1 Composition comprising propolis and at least an essential oil |
| 02/11/1999 | WO1999006057A1 Soya extract, process for its preparation and pharmaceutical composition |
| 02/11/1999 | WO1999006044A1 Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation |
| 02/10/1999 | CN1207670A Cosmetic composition and method for reducing ageing processes of skin |
| 02/04/1999 | WO1999004770A2 A pharmaceutical composition active in reducing production of mcp-1 protein |
| 02/04/1999 | WO1999004765A2 Pharmaceutical compositions containing an effervescent acid-base couple |
| 01/28/1999 | WO1999003859A1 Novel spiroazabicyclic heterocyclic compounds |
| 12/17/1998 | WO1998056387A1 Method of treatment of liver tumours and pharmaceutical compositions for use therein |
| 12/03/1998 | WO1998054171A1 Novel form of s-omeprazole |
| 11/18/1998 | EP0878199A1 Natural teas for taking off the effects of drink and process for the production thereof |
| 10/14/1998 | EP0869771A1 A cosmetic composition and a method for reducing the ageing processes of skin |
| 09/11/1998 | WO1998039012A1 USE OF A 7α-METHYL-17α-ETHYNYL-ESTRANE DERIVATIVE FOR THE TREATMENT OF ATHEROSCLEROSIS |
| 09/11/1998 | CA2283418A1 Use of a 7.alpha.-methyl-17.alpha.-ethynyl-estrane derivative for the treatment of atherosclerosis |
| 08/26/1998 | CN1191481A Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof |
| 06/18/1998 | WO1998018477A3 Pharmaceutical compositions containing lamivudine and zidovudine |
| 06/17/1998 | CN1185110A Synergistic combination of zidovudine |
| 06/03/1998 | CN1183722A Use of penciclovir for treatment of human herpes-virus-8 |
| 05/14/1998 | WO1998019688A1 Pharmaceutical composition for treatment of diabetes |
| 05/14/1998 | WO1998019687A1 Natural teas for taking off the effects of drink and process for the production thereof |
| 05/07/1998 | WO1998018477A2 Pharmaceutical compositions containing lamivudine and zidovudine |
| 05/07/1998 | CA2270174A1 Pharmaceutical compositions containing lamivudine and zidovudine |
| 04/28/1998 | US5744500 Administering to treat brain ischemia or stroke |
| 03/18/1998 | EP0828494A1 Method for treating cognitive dysfunction |
| 03/18/1998 | EP0828485A1 Use of r-enantiomer of n-propargyl-1-aminoindan, salts, and compositions thereof |
| 02/03/1998 | US5714520 Propofol compostion containing edetate |
| 01/14/1998 | EP0817637A1 Synergistic combinations of zidovudine, 1592u89 and 3tc or ftc |
| 01/07/1998 | EP0814813A2 Use of penciclovir for the treatment of human herpes-virus-8 |
| 01/07/1998 | EP0814787A1 Oil in water emulsions containing propofol and edetate |
| 11/26/1997 | CN1165665A Medicinal compsn. for treatment of spur and its prepn. |
| 11/13/1997 | WO1997041874A1 Phosphatidic acid-comprising compositions |
| 11/05/1997 | CN1163936A Recombination eukaryotic vector containing sensitinogen gene and application thereof |
| 11/05/1997 | CN1163934A Protein with thrombocytopoietic factor active |
| 11/05/1997 | CN1163933A Protein with thrombocytopoietic factor active |
| 09/10/1997 | EP0699073A4 Allogeneic and xenogeneic transplantation |
| 07/03/1997 | WO1997023198A1 A cosmetic composition and a method for reducing the ageing processes of skin |
| 07/03/1997 | CA2240505A1 A cosmetic composition and a method for reducing the ageing processes of skin |
| 06/11/1997 | CN1151699A Health compsn. |
| 04/16/1997 | EP0768089A1 Health composition |
| 01/16/1997 | WO1996027378A3 Use of penciclovir for the treatment of human herpes-virus-8 |
| 12/05/1996 | WO1996038151A1 Method for treating cognitive dysfunction |
| 11/28/1996 | WO1996037199A1 Use of r-enantiomer of n-propargyl-1-aminoindan, salts, and compositions thereof |
| 11/28/1996 | CA2221458A1 Use of r-enantiomer of n-propargyl-1-aminoindan, salts, and compositions thereof |
| 10/23/1996 | EP0576643B1 Controlled release oxycodone compositions |
| 10/03/1996 | WO1996030025A1 Synergistic combinations of zidovudine, 1592u89 and 3tc or ftc |
| 10/01/1996 | US5561138 Administering rapamycin by mouth, injection, nose, bronchi, skin or rectum; treating autoimmune hemolytic (warm or cold), transient drug induced, alloimmune or aplastic anemia |
| 09/26/1996 | WO1996029064A1 Oil in water emulsions containing propofol and edetate |
| 09/19/1996 | DE19509828A1 Oil-in-water emulsion for parenteral admin. contg. EDTA as antimicrobial agent |
| 09/18/1996 | CN1131438A Protein having TPO activity |
| 09/12/1996 | WO1996027378A2 Use of penciclovir for the treatment of human herpes-virus-8 |
| 08/27/1996 | US5549912 Controlled release oxycodone compositions |
| 07/24/1996 | EP0722730A1 Controlled release oxycodone compositions |
| 06/19/1996 | EP0716857A1 Use of rapamycin for treating anemia |
| 06/14/1996 | CA2164921A1 Method of treating anemia |
| 04/16/1996 | US5508042 Administering an oral dosage every 12 hours |
| 03/06/1996 | EP0699073A1 Allogeneic and xenogeneic transplantation |
| 02/07/1996 | EP0695355A1 Protein having tpo activity |
| 01/11/1996 | WO1996000580A1 Health composition |
| 08/17/1995 | CA2160591A1 Protein having tpo activity |
| 01/04/1995 | CN1027267C Method for preparing of N-acyl derivatives of LL-E33288 antitumor antibiotics |
| 11/24/1994 | CA2162496A1 Allogeneic and xenogeneic transplatation |
| 06/01/1994 | CN1087262A Controlied release oxycodone compositions |
| 11/30/1993 | US5266331 Controlled release oxycodone compositions |
| 05/28/1993 | WO1993010765A1 Controlled release oxycodone compositions |
| 01/07/1992 | US5079233 N-acyl derivatives of the LL-E33288 antitumor antibiotics, composition and methods for using the same |
| 01/09/1991 | CN1048390A N-acyl derivatives of ll-e 33288 antitumor antibiotics |
| 10/17/1990 | EP0392376A2 N-acyl derivatives of the LL-E33288 antitumor antibiotics |